Sep 2026 (Q3 FY26) — Oct 22, 2026
Enova International Q3 FY26 — Record Revenue and Strong Profitability
Read the full callEnova International earnings: last reported Thu, 22 Oct 2026, for the quarter ended Sep 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,009 | +25.7% YoY | Quarterly, as filed | Quarter to Sep 2026 | Revenue from operations as filed. |
| Operating margin | 24.5 | −0.0 pts YoY | Operating profit / revenue | Quarter to Sep 2026 | For the quarter; a change is in percentage points. |
| Net profit | 107 | +33.6% YoY | Quarterly, as filed | Quarter to Sep 2026 | Profit after tax as filed. |
Price
1Y: $113.95 on 22 Oct 2025 → $165.07. High $265.45 (14 Aug 2026), low $113.95 (22 Oct 2025).
Overview
Call summaries
Enova International Q3 FY26 — Record Revenue and Strong Profitability
Read the full callEnova International Q2 FY26 — Strong Originations and Adjusted EPS Growth, Raised Full-Year Outlook
Read the full callEnova International Q1 FY26 — Strong Originations and Credit Drive Record Revenue and EPS Growth
Read the full callEvery analysed call
Financials
Net profit, year on year: +34% (quarter to sep 2026 against sep 2025).
| Line item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 730 | 746 | 764 | 803 | 839 | 875 | 929 | 1,009 |
| Operating profit | 155 | 172 | 184 | 197 | 187 | 207 | 237 | 247 |
| Operating margin | 21.3% | 23.1% | 24.1% | 24.5% | 22.2% | 23.7% | 25.5% | 24.5% |
| Interest | 77 | 81 | 83 | 87 | 89 | 94 | 98 | 104 |
| Profit before tax | 77 | 91 | 101 | 110 | 99 | 113 | 140 | 143 |
| Tax rate | 17.7% | 19.9% | 24.6% | 27.1% | 20.1% | 19.3% | 25.0% | 24.9% |
| Net profit | 64 | 73 | 76 | 80 | 79 | 91 | 105 | 107 |
| EPS ($ per share) | — | 2.84 | 3.01 | 3.22 | — | 3.66 | 4.22 | 4.31 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 336 | 373 | 849 | 1,106 | 1,313 | 1,488 | 1,698 | 2,006 |
| Total liabilities | 987 | 1,198 | 1,189 | 1,668 | 2,595 | 3,345 | 4,069 | 5,132 |
| Fixed assets | 46 | 55 | 79 | 78 | 93 | 109 | 120 | 133 |
| Total assets | 1,334 | 1,574 | 2,108 | 2,761 | 3,781 | 4,586 | 5,266 | 6,468 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 685 | 849 | 741 | 472 | 894 | 1,167 | 1,539 | 1,819 |
| Cash from investing | -721 | -941 | 84 | -980 | -1,666 | -1,495 | -1,911 | -2,446 |
| Cash from financing | 22 | 95 | -536 | 365 | 725 | 527 | 319 | 712 |
| Net cash flow | -21 | 4 | 288 | -143 | -47 | 199 | -55 | 85 |
| Capital expenditure | -15 | -20 | -29 | -30 | -44 | -45 | -43 | -47 |
| Free cash flow | 670 | 829 | 711 | 442 | 850 | 1,122 | 1,495 | 1,772 |
87 filings between Oct 27, 2025 and Sep 17, 2026.
Purchases
None
No insider bought shares.
Sales
$57.07M
28 sales by 7 insiders
36% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 2 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Fisher David | — | $39.21M | Sep 17, 2026 |
| TEBBE MARK | — | $7.47M | Jun 18, 2026 |
| Cunningham Steven E | — | $3.67M | Apr 28, 2026 |
| GOODYEAR WILLIAM M | — | $2.67M | Jun 16, 2026 |
| Rahilly Sean | — | $2.12M | Jan 30, 2026 |
| Gray James A | — | $1.72M | Feb 2, 2026 |
| RICE LINDA JOHNSON | — | $209.6K | May 29, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 20,750 | $430.1K |
| Sep 17, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 20,750 | $3.70M |
| Aug 26, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 9,078 | $188.2K |
| Aug 26, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 9,078 | $2.17M |
| Aug 25, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 9,491 | $2.32M |
| Aug 25, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 9,491 | $196.7K |
| Aug 5, 2026 | Veltre Maria Director | Award | 772 | $0 |
| Jul 15, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 11,494 | $2.66M |
| Jul 15, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 11,494 | $238.3K |
| Jul 14, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 17,006 | $3.94M |
| Jul 14, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 17,006 | $352.5K |
| Jun 18, 2026 | TEBBE MARK Director | Sale | 20,000 | $4.03M |
| Jun 17, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 33,060 | $685.3K |
| Jun 17, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 33,060 | $6.58M |
| Jun 16, 2026 | GOODYEAR WILLIAM M Director | Sale | 3,500 | $658.1K |
| Jun 12, 2026 | GOODYEAR WILLIAM M Director | Gift | 8,437 | $0 |
| Jun 1, 2026 | GOODYEAR WILLIAM M Director | Sale | 5,983 | $976.0K |
| May 29, 2026 | RICE LINDA JOHNSON Director | Sale | 1,300 | $209.6K |
| May 22, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 3,076 | $63.8K |
| May 22, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 3,076 | $487.4K |
| May 21, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 7,180 | $1.15M |
| May 21, 2026 | Fisher David Executive Chairman | Option exercise 10b5-1 plan | 7,180 | $148.8K |
| May 18, 2026 | GOODYEAR WILLIAM M Director | Sale | 6,231 | $1.03M |
| May 13, 2026 | CARNAHAN ELLEN Director | Award | 1,320 | $0 |
| May 13, 2026 | Gray James A Director | Award | 1,320 | $0 |
| May 13, 2026 | KAPLAN GREGG A. Director | Award | 1,320 | $0 |
| May 13, 2026 | GOODYEAR WILLIAM M Director | Award | 1,320 | $0 |
| May 13, 2026 | RICE LINDA JOHNSON Director | Award | 1,320 | $0 |
| May 13, 2026 | McGowan Mark Director | Award | 1,320 | $0 |
| May 13, 2026 | TEBBE MARK Director | Award | 1,320 | $0 |
| May 13, 2026 | Corby Lindsay Y Director | Award | 1,320 | $0 |
| May 13, 2026 | FEEHAN DANIEL R Director | Award | 1,320 | $0 |
| May 10, 2026 | Cornelis Scott Chief Financial Officer | Tax withheld | 544 | $95.1K |
| May 7, 2026 | Fisher David Executive Chairman | Sale | 20,000 | $3.46M |
| Apr 28, 2026 | Cunningham Steven E Chief Executive Officer | Sale | 3,696 | $648.6K |
| Apr 28, 2026 | Cunningham Steven E Chief Executive Officer | Option exercise | 3,696 | $118.2K |
| Apr 28, 2026 | Cunningham Steven E Chief Executive Officer | Sale | 4,156 | $729.4K |
| Feb 18, 2026 | Fisher David Executive Chairman | Sale 10b5-1 plan | 7,143 | $1.07M |
| Feb 11, 2026 | Lee James Joseph Chief Accounting Officer | Award | 3,723 | $0 |
| Feb 11, 2026 | Rahilly Sean General Counsel and Secretary | Award | 9,474 | $0 |
| Feb 11, 2026 | Cornelis Scott Chief Financial Officer | Award | 3,276 | $0 |
| Feb 11, 2026 | Fisher David Executive Chairman | Award | 13,515 | $0 |
| Feb 11, 2026 | Cunningham Steven E Chief Executive Officer | Award | 16,067 | $0 |
| Feb 11, 2026 | Chartier Kirk Chief Strategy Officer | Award | 4,573 | $0 |
| Feb 8, 2026 | Lee James Joseph Chief Accounting Officer | Tax withheld | 251 | $40.4K |
| Feb 8, 2026 | Cunningham Steven E Chief Executive Officer | Tax withheld | 5,209 | $839.2K |
| Feb 8, 2026 | Rahilly Sean General Counsel and Secretary | Tax withheld | 843 | $135.8K |
| Feb 8, 2026 | Lee James Joseph Chief Accounting Officer | Tax withheld | 246 | $39.6K |
| Feb 8, 2026 | Cornelis Scott Chief Financial Officer | Tax withheld | 242 | $39.0K |
| Feb 8, 2026 | Chartier Kirk Chief Strategy Officer | Tax withheld | 1,791 | $288.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Enova International, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading